Explore comprehensive studies on parasite biology, host interactions, and disease control strategies
Discover how DNDI-6174, a novel drug candidate, targets the cytochrome bc1 complex to combat visceral leishmaniasis, a deadly parasitic disease affecting millions worldwide.